Physician

Daniel Lawrence Feiler, M.D.

According to 2025 Medicare claims, Daniel Feiler, M.D. (NPI: 1245572916) practices ophthalmology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is RETINA ASSOCIATES LLC (NPI: 1609818913; TIN: 481211774) and primary practice location at 66615-1004.

Feiler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,617 traditional Medicare patients, billed 43,617 HCPCS/CPT codes, and received $5,603,043 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 464 prescription claims across 187 beneficiaries totaling $16,199 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 29 records totaling $26,570. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $62,209 to $5,603,043. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,750 and ending at $16,199. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.8M$5.6M2017 Medicare payment: $62,209 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $52,949 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $399,753 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,491,625 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,371,498 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,164,544 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,857,173 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,603,043 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20174111,027$62,209
20184041,030$52,949
20193731,851$399,753
20208239,537$2,491,625
20211,07911,972$3,371,498
20221,25715,715$4,164,544
20231,45329,012$4,857,173
20241,61743,617$5,603,043

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2015 Drug cost: $19,750 (USD; Tot_Drug_Cst)2016 Drug cost: $12,780 (USD; Tot_Drug_Cst)2017 Drug cost: $14,432 (USD; Tot_Drug_Cst)2018 Drug cost: $34,557 (USD; Tot_Drug_Cst)2019 Drug cost: $10,650 (USD; Tot_Drug_Cst)2020 Drug cost: $14,667 (USD; Tot_Drug_Cst)2021 Drug cost: $12,300 (USD; Tot_Drug_Cst)2022 Drug cost: $14,705 (USD; Tot_Drug_Cst)2023 Drug cost: $19,882 (USD; Tot_Drug_Cst)2024 Drug cost: $16,199 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015107343$19,750
2016120384$12,780
201785246$14,432
2018118312$34,557
201985210$10,650
2020115264$14,667
2021110292$12,300
2022143339$14,705
2023161375$19,882
2024187464$16,199

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg4695,480$649
67028Injection of drug into eye5962,867$100
92014Established patient complete exam of visual system9821,417$85
92134Imaging of retina1,4094,158$28
92250Photography of the retina459577$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate441,411$5,432
Prednisolone AcetatePrednisolone Acetate1424,291$4,584
OfloxacinOfloxacin972,120$1,053
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat524,223$901
Atropine SulfateAtropine Sulfate12454$410

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$744Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.6$25,826Alimera Sciences, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Lawrence Feiler, M.D.?

Tedicare shows public-source Medicare data for Daniel Lawrence Feiler, M.D. (NPI 1245572916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Lawrence Feiler, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Lawrence Feiler, M.D.?

Daniel Lawrence Feiler, M.D. is linked to RETINA ASSOCIATES LLC (billing NPI 1609818913) in the available physician profile data.

Does Daniel Lawrence Feiler, M.D. have Open Payments data?

Daniel Lawrence Feiler, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.